Naloxone benzoylhydrazone (NalBzoH) 是一种混合的激动剂/拮抗剂。Naloxone benzoylhydrazone 是原型 κ3 -阿片样受体激动剂，是克隆的 μ 和 δ 阿片样受体的部分激动剂，在阿片样 NOP 受体上是拮抗剂。Naloxone benzoylhydrazone 可用于缓解疼痛的研究。

Naloxone benzoylhydrazone (NalBzoH) is a mixed agonist/antagonist. Naloxone benzoylhydrazone is a prototypic κ3-opioid receptor agonist, and a partial agonist at the cloned μ and δ opioid receptors, and an antagonist at opioid-like NOP receptors. Naloxone benzoylhydrazone has potently analgesia effect.

Solid

κ3-opioid receptor; μ- and δ-opioid receptors; Opioid-like NOP receptors

At the mu-opioid receptor (MOR), Naloxone benzoylhydrazone stimulates [S]GTPγS binding (pEC50=8.59) and inhibits cyclic AMP accumulation (pEC50=8.74) with maximal effects (Emax) corresponding to 55 and 65% of those obtained with the MOR agonist DAMGO, respectively.
At the κ-opioid receptor (KOR), Naloxone benzoylhydrazone stimulates [S]GTPγS binding (pEC50=9.70) and inhibits cyclic AMP formation (pEC50=9.45) .
In CHO cells expressing the δ-opioid receptor (DOR), Naloxone benzoylhydrazone increases [S]GTPγS binding (pEC50=8.49) and inhibits cyclic AMP formation (pE50=8.61). has not independently confirmed the accuracy of these methods. They are for reference only.

Analgesic studies in mice examining increasing doses of Naloxone benzoylhydrazone with a fixed dose of morphine reveals a biphasic curve. Naloxone benzoylhydrazone at doses as low as 1 μg/kg partially antagonized morphine analgesia. Higher Naloxone benzoylhydrazone doses continued to inhibit morphine analgesia in a dose-dependent manner, with the 1-mg/kg dose antagonizing completely morphine analgesia. As the Naloxone benzoylhydrazone dose increased beyond 1 mg/kg analgesia returned. Naloxone benzoylhydrazone also prduces a similar analgesic response when administered alone in mice and also is active in rats. Naloxone benzoylhydrazone has excellent p.o. activity, with an analgesic potency in mice equivalent to s.c. administration. In addition to blocking morphine analgesia, low doses of Naloxone benzoylhydrazone also partially reverses the inhibition of gastrointestinal transi

Room temperature in continental US; may vary elsewhere.

Powder -20°C 3 years；4°C 2 years

[1]. Olianas MC, et al. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors. Br J Pharmacol. 2006 Feb;147(4):360-70.
[2]. Connor M, et al. Has the sun set on kappa3-opioid receptors? Br J Pharmacol. 2006 Feb;147(4):349-50.
[3]. Paul D, et al. Naloxone benzoylhydrazone (NalBzoH) a